Dormant origins licensed by excess Mcm2 7 are required for human cells to survive replicative stress.

Dormant origins licensed by excess Mcm2 7 are required for human cells to survive replicative stress. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Dormant origins licensed by excess Mcm2 7 are required for human cells to survive replicative stress. Abstract Text:

Xin Quan Ge,Dean A Jackson,J Julian Blow,Xin Quan Ge,Dean A Jackson,J Julian Blow,

In late mitosis and early G1, Mcm2-7 complexes are loaded onto DNA to license replication origins for use in the upcoming S phase. However, the amount of Mcm2-7 loaded is in significant excess over the number of origins normally used. We show here that in human cells, excess chromatin-bound Mcm2-7 license dormant replication origins that do not fire during normal DNA replication, in part due to checkpoint activity. Dormant origins were activated within active replicon clusters if replication fork progression was inhibited, despite the activation of S-phase checkpoints. After lowering levels of chromatin-bound Mcm2-7 in human cells by RNA interference (RNAi), the use of dormant origins was suppressed in response to replicative stress. Although cells with lowered chromatin-bound Mcm2-7 replicated at normal rates, when challenged with replication inhibitors they had dramatically reduced rates of DNA synthesis and reduced viability. These results suggest that the use of dormant origins licensed by excess Mcm2-7 is a new and physiologically important mechanism that cells utilize to maintain DNA replication rates under conditions of replicative stress. We propose that checkpoint kinase activity can preferentially suppress initiation within inactive replicon clusters, thereby directing new initiation events toward active clusters that are experiencing replication problems.

Dormant origins licensed by excess Mcm2 7 are required for human cells to survive replicative stress. Publishing Authors By Initials

XQ Ge,DA Jackson,JJ Blow,XQ Ge,DA Jackson,JJ Blow,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Dormant origins licensed by excess Mcm2 7 are required for human cells to survive replicative stress. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Genes & development

VOLUME: 21

Page Numbers: 3331-41

Journal Abbreviation: Genes Dev.

ISSN: 0890-9369

DAY: 15

MONTH: Dec

YEAR: 2007

Dormant origins licensed by excess Mcm2 7 are required for human cells to survive replicative stress. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8711660

Dormant origins licensed by excess Mcm2 7 are required for human cells to survive replicative stress. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Dormant origins licensed by excess Mcm2 7 are required for human cells to survive replicative stress. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Dormant origins licensed by excess Mcm2 7 are required for human cells to survive replicative stress.

AFFILIATION: Wellcome Trust Biocentre, University of Dundee, Dundee DD1 5EH, United Kingdom;

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Genes Dev

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Dormant origins licensed by excess Mcm2 7 are required for human cells to survive replicative stress Related Publications

• Access to and satisfaction with care comparing patients with and without serious mental illness.
• Boy or girl--parental choice?
• Brief alcohol intervention in the emergency department: moderators of effectiveness.
• DNA sequencing: generation next-next.
• Dormant origins licensed by excess Mcm2 7 are required for human cells to survive replicative stress.
• ELYS/MEL-28 chromatin association coordinates nuclear pore complex assembly and replication licensing.
• Gender differences in health-related quality of life for veterans with serious mental illness.
• Genomics: when the chemistry is good.
• Improving Integrated General Medical and Mental Health Services in Community-based Practices.
• Lab automation: tales along the road to automation.
• Metabolomics: Biochemistry's new look.
• Metagenomics: exploring unseen communities.
• Nanotechnology in biology: big collaborations for a small world.
• Nanotechnology: Could it be a small world after all?
• Nutrition and exercise behavior among patients with bipolar disorder.
• Oral health in Veterans Affairs patients diagnosed with serious mental illness.
• POLYVALENT INFLUENZA VACCINE IN GENERAL PRACTICE.
• PTIP/Swift is required for efficient PCNA ubiquitination in response to DNA damage.
• Psychiatric diagnosis and intervention in older and younger patients in a primary care clinic: effect of a screening and diagnostic instrument.
• Quality of Care for Cardiovascular Disease-related Conditions in Patients with and without Mental Disorders.
• RNAi technologies: a screen whose time has arrived.
• Rapid induction of pluripotency genes after exposure of human somatic cells to mouse ES cell extracts.
• Reinstitutionalization following psychiatric discharge among VA patients with serious mental illness: a national longitudinal study.
• Small RNAs: Delivering the future.
• Social support among veterans with serious mental illness.
• Stem cells: in search of common ground.
• Structural genomics: inside a protein structure initiative center.
• Temporal Profiling of the Chromatin Proteome Reveals System-wide Responses to Replication Inhibition.
• Understanding associations between serious mental illness and HIV among patients in the VA Health System.
• Unhealthy drinking patterns in older adults: prevalence and associated characteristics.